The effect of recombinant human interferon α compared to interferon α 2b on SIV infection in rhesus macaques
- 31 August 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 32 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interferons in HIV and related diseasesAIDS, 1994
- Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN–α) during therapy for chronic hepatitis CClinical and Experimental Immunology, 1994
- Interferons in the pathogenesis and treatment of human immunodeficiency virus infectionAntiviral Research, 1994
- Combination Therapy for Infection Due to Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 1994
- Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for TherapyScience, 1993
- A Formalin-Inactivated Whole SIV Vaccine Confers Protection in MacaquesScience, 1989
- Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus (SIVmac 251)AIDS, 1989
- CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMAThe Lancet, 1988
- Neutralization of Interferon by Antibody: Appraisals of Methods of Determining and Expressing the Neutralization TiterJournal of Interferon Research, 1984
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983